Delivery Order SPE2DB22D3301-SPE2DB25FY9ZD
- Not listed
- The Defense Logistics Agency awarded a $36,799.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Pirfenidone 267 mg capsules (270-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pirfenidone 267 mg tablets (90-count supply) under a firm fixed price contract valued at $46,234.38. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Pirfenidone is an antifibrotic agent commonly used in the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $14,296.48 delivery order contract is for the supply of 4564002351 Pirfenidone 801 mg tablets to support military treatment programs and facilities. The contract is a firm fixed price arrangement with a performance period ending on March 19, 2024. AmerisourceBergen Drug Corp serves as the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,370.34 firm fixed-price delivery order is for the supply of 4,566,831,885 units of the drug Pirfenidone 267 mg Tablet in 90-count bottles. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Pirfenidone 267 mg capsules, with a ceiling value of $22,963.58 and a completion date of May 29, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,236.83 by the Defense Logistics Agency (DLA) to provide 4563849239 - Pirfenidone 801 mg Tablets, 90 count. The contract has a completion date of March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,242 to AmerisourceBergen Drug Corporation for 4562125873 PIRFENIDONE 267 MG TABLET 90S. The prime contractor, AmerisourceBergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a contract start and end date of September 11-12, 2023. No major subcontractors or set aside designations were indicated. The Defense...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $54,171.98, is for the delivery of Pirfenidone 267 mg capsules. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through March 2025. No set-aside designation is noted. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,491.81 firm-fixed-price delivery order is for the supply of PIRFENIDONE 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Pirfenidone 267 mg capsules. The contract has a ceiling value of $17,787.38 and a completion date of April 9, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for providing a...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9ZDDelivery Order
The Defense Logistics Agency awarded a $23,872.20 delivery order to AmerisourceBergen Drug Corp for the supply of Pirfenidone 267 mg tablets (270 count) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a significant supplier to the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related healthcare commodities to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order represents a routine pharmaceutical procurement fulfilling federal healthcare supply requirements for defense and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.9k | 8/25/25 |